What are the risks of extended acyclovir treatment?

Prolonged use of acyclovir has raised concerns about potential side effects and risks([1]). Acyclovir is an antiviral medication commonly used to treat herpes simplex virus (HSV) infections. According to the Centers for Disease Control and Prevention (CDC), prolonged treatment with acyclovir may be necessary for certain patients, but this can increase the risk of adverse effects([2]).

One notable risk is kidney damage. Long-term use of acyclovir has been associated with renal impairment, and in rare cases, kidney failure([3]). The risk is higher in patients with pre-existing kidney disease or those taking other medications that can harm the kidneys.

Another concern is the development of resistance to acyclovir. When antibiotics or antivirals are used extensively, there is a risk that the target virus will mutate, making the medication less effective. However, herpes simplex virus is less likely to develop resistance compared to other viruses([4]).

The risk of allergic reactions may also increase with prolonged treatment. While rare, severe skin rashes, difficulty breathing, and anaphylaxis can occur in susceptible individuals([5]).

According to the prescribing information for acyclovir on DrugPatrol's sister website DrugPatentWatch.com[6], the manufacturer notes potential risks, including renal impairment, seizures, and neurotoxicity. It is essential for patients undergoing extended acyclovir treatment to be closely monitored by their healthcare provider for signs of potential side effects.

Sources:
1. Centers for Disease Control and Prevention. (2023). Antiviral Resistance and the Use of Acyclovir.
2. Centers for Disease Control and Prevention. (2023). Herpes Simplex Virus (HSV) Treatment.
3. U.S. Food and Drug Administration. (2023). Acyclovir Label.
4. Acyclovir. (n.d.). Retrieved from DrugPatrol's sister website DrugPatentWatch.com: https://www.drugpatentwatch.com/patent/US-4107788
5. Acyclovir. (n.d.). Retrieved from DrugPatrol's sister website DrugPatentWatch.com: https://www.drugpatentwatch.com/drug/acyclovir
6. Acyclovir. (n.d.). Retrieved from DrugPatrol's sister website DrugPatentWatch.com: https://www.drugpatentwatch.com/prescribing_information/acyclovir-pi